Growth in the US medical & dental adhesives & sealants market will total 5.1% annually through 2019 in value terms. Gains will be fueled by the rising use of tissue sealants and hemostats over alternative wound closure technologies. Recent FDA approvals of combined synthetic & biologics-based sealants will also benefit demand.
This report segments the Medical & Dental Adhesives & Sealants industry by Products, Applications, and Markets. Data is provided in million US dollars and million milliliters.
Acrylic adhesives will remain the largest of these through 2019. Fastest growth will be for polyethylene glycol products, driven by increasing use of PROGEL (CR Bard) and RESURE (Ocular Therapeutics) PEG-based tissue sealants.
Major Medical & Dental Adhesives & Sealants Applications include:
Internal Medical was the leading application in 2014. The most rapid gains through 2019 are forecast for pulmonary applications, fueled by the rapid adoption of tissue sealants and adhesives to reduce leakage in the lungs during pulmonary procedures.
Among the key Markets for Medical & Dental Adhesives & Sealants are:
Primary Care was the largest market in 2014. Going forward, primary care will also see the strongest advances, as most of the growth in the medical & dental adhesives & sealants industry is in surgical and wound closure uses.
Entry into the US medical and dental adhesives and sealants industry is relatively difficult due to high product development costs and the need for vigorous testing procedures before commercialization. Suppliers include Baxter International, CR Bard, Cryolife, DENTSPLY, GlaxoSmithKline, Integra LifeSciences, Johnson & Johnson, Pfizer, Procter & Gamble, Stryker, 3M, and Zimmer Biomet.